Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation

NACompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2012

Study Completion Date

April 30, 2014

Conditions
Mid-facial Volume Deficit Related to Aging
Interventions
DEVICE

Juvéderm® VOLUMA XC

Treating Investigator determines the appropriate volume of VOLUMA XC to be injected up to a maximum total of 12 mL for initial and touch-up treatment. One repeat treatment with up to 12 mL may be performed at the Subject's option after study completion.

Trial Locations (2)

Unknown

Los Angeles

Vancouver

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00978042 - Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation | Biotech Hunter | Biotech Hunter